The Medical Letter on Drugs and Therapeutics
Drugs for Female Sexual Dysfunction
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

Sexual complaints related to desire, arousal, orgasm and painful intercourse are common in women.1 Since the last Medical Letter article on this subject,2 some new information has become available.

ESTROGEN — Treatment of postmenopausal women with systemic or vaginal estrogen can increase glandular secretions and the thickness and elasticity of the vagina, reversing the vaginal atrophy and dryness that can cause dyspareunia and other sexual pain syndromes.3 Vaginal estrogens may be more effective than oral estrogens for treatment of vaginal symptoms. Systemic estrogen therapy can be particularly helpful for female sexual dysfunction associated with hot flushes and night sweats. There are no convincing data that estrogen therapy enhances desire, arousal or sexual response in the absence of vaginal or vasomotor symptoms.

Adverse ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Female Sexual Dysfunction
Article code: 1353c
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian